[
    {
        "id": "jun-easy-1",
        "query": " Based on the charges associated with the Allergan acquisition integration plan, what was the total cost incurred by the company in 2023, and how does it compare to the costs in 2022?",
        "answer": "The total charges in 2023 were $288 millions, and 2023 charges are lower than 2022 charges by $251 millions.",
        "answer_type": "string_approximate",
        "data_sources": [
            "<body><div style=\"min-height:45pt;width:100%\"><div><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">                                                         </span></div></div><ix:continuation id=\"f-786-2\"><ix:nonnumeric contextref=\"c-137\" escape=\"true\" id=\"f-788\" name=\"us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock\"><div style=\"margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">The following table summarizes the charges associated with the Allergan acquisition integration plan:</span><table style=\"border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%\"><tr><td style=\"width:1.0%\"></td><td style=\"width:31.209%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.384%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.572%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.384%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.572%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.384%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.572%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.384%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.572%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.530%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.572%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.384%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.581%\"></td><td style=\"width:0.1%\"></td></tr><tr><td colspan=\"3\" style=\"padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">year ended December 31 (in millions)</span></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:2px 1pt;text-align:center;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">2023</span></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:2px 1pt;text-align:center;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">2022</span></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:2px 1pt;text-align:center;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">2021</span></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><span style=\"-sec-ix-hidden:f-789\"><span style=\"-sec-ix-hidden:f-790\"><span style=\"-sec-ix-hidden:f-791\">Cost of products sold</span></span></span></span></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-138\" decimals=\"-6\" id=\"f-792\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">89</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt\"></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-139\" decimals=\"-6\" id=\"f-793\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">117</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt\"></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-140\" decimals=\"-6\" id=\"f-794\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">132</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Research and development</span></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-141\" decimals=\"-6\" id=\"f-795\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">7</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-142\" decimals=\"-6\" id=\"f-796\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">23</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-143\" decimals=\"-6\" id=\"f-797\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">102</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Selling, general and administrative</span></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-144\" decimals=\"-6\" id=\"f-798\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">192</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-145\" decimals=\"-6\" id=\"f-799\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">399</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-146\" decimals=\"-6\" id=\"f-800\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">353</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Total charges </span></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-147\" decimals=\"-6\" id=\"f-801\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">288</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt\"></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-148\" decimals=\"-6\" id=\"f-802\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">539</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt\"></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-149\" decimals=\"-6\" id=\"f-803\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">587</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr></table></div></ix:nonnumeric><ix:nonnumeric contextref=\"c-137\" escape=\"true\" id=\"f-804\" name=\"us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock\"><div style=\"margin-bottom:8pt;margin-top:10pt;text-indent:24.75pt\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">The following table summarizes the cash activity in the recorded liability associated with the integration plan: </span><table style=\"border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%\"><tr><td style=\"width:1.0%\"></td><td style=\"width:76.239%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.864%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.530%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.867%\"></td><td style=\"width:0.1%\"></td></tr><tr><td colspan=\"3\" style=\"padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">year ended December 31 (in millions)</span></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2020</span></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-150\" decimals=\"-6\" id=\"f-805\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">387</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges</span></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-149\" decimals=\"-6\" id=\"f-806\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">526</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-149\" decimals=\"-6\" id=\"f-807\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">658</ix:nonfraction>)</span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2021</span></td><td colspan=\"3\" style=\"background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-151\" decimals=\"-6\" id=\"f-808\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">255</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges</span></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-148\" decimals=\"-6\" id=\"f-809\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">377</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-148\" decimals=\"-6\" id=\"f-810\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">525</ix:nonfraction>)</span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2022</span></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-152\" decimals=\"-6\" id=\"f-811\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">107</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges </span></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-147\" decimals=\"-6\" id=\"f-812\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">274</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-147\" decimals=\"-6\" id=\"f-813\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">338</ix:nonfraction>)</span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2023</span></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt\"></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-153\" decimals=\"-6\" id=\"f-814\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">43</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr></table></div></ix:nonnumeric><div style=\"margin-bottom:8pt;margin-top:8pt\"><span style=\"color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%\">Other Restructuring</span></div><div style=\"margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">AbbVie continuously evaluates its operations to identify opportunities to optimize its manufacturing and R&amp;D operations, commercial infrastructure and administrative costs and to respond to changes in its business environment. As a result, AbbVie management periodically approves individual restructuring plans to achieve these objectives. In 2023, 2022 and 2021, no such plans were individually significant. Restructuring charges recorded were $<ix:nonfraction contextref=\"c-154\" decimals=\"-6\" format=\"ixt:num-dot-decimal\" id=\"f-815\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">132</ix:nonfraction> million in 2023, $<ix:nonfraction contextref=\"c-155\" decimals=\"-6\" format=\"ixt:num-dot-decimal\" id=\"f-816\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">241</ix:nonfraction> million in 2022 and $<ix:nonfraction contextref=\"c-156\" decimals=\"-6\" format=\"ixt:num-dot-decimal\" id=\"f-817\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">59</ix:nonfraction> million in 2021 and were primarily related to employee severance and contractual obligations. These charges were recorded in cost of products sold, R&amp;D expense and SG&amp;A expenses in the consolidated statements of earnings based on the classification of the affected employees or operations.</span></div><ix:nonnumeric contextref=\"c-157\" escape=\"true\" id=\"f-818\" name=\"us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock\"><div style=\"margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">The following table summarizes the cash activity in the restructuring reserve for 2023, 2022 and 2021:</span></div><div style=\"margin-bottom:8pt;margin-top:8pt\"><table style=\"border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%\"><tr><td style=\"width:1.0%\"></td><td style=\"width:86.162%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:11.638%\"></td><td style=\"width:0.1%\"></td></tr><tr><td colspan=\"3\" style=\"padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">(in millions)</span></td><td colspan=\"3\" style=\"padding:0 1pt\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2020</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-158\" decimals=\"-6\" id=\"f-819\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">90</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><div><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges</span></div></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-159\" decimals=\"-6\" id=\"f-820\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">54</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-159\" decimals=\"-6\" id=\"f-821\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">111</ix:nonfraction>)</span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2021</span></td><td colspan=\"2\" style=\"background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-160\" decimals=\"-6\" id=\"f-822\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">33</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><div><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges</span></div></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-161\" decimals=\"-6\" id=\"f-823\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">193</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-161\" decimals=\"-6\" id=\"f-824\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">50</ix:nonfraction>)</span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2022</span></td><td colspan=\"2\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-162\" decimals=\"-6\" id=\"f-825\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">176</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><div><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges</span></div></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-157\" decimals=\"-6\" id=\"f-826\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">107</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-157\" decimals=\"-6\" id=\"f-827\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">87</ix:nonfraction>)</span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2023</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-163\" decimals=\"-6\" id=\"f-828\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">196</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr></table></div></ix:nonnumeric></ix:continuation><div style=\"height:45pt;position:relative;width:100%\"><div style=\"bottom:0;position:absolute;width:100%\"><div style=\"text-align:center\"><table style=\"border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%\"><tr><td style=\"width:1.0%\"></td><td style=\"width:32.233%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:27.681%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:32.673%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:3.013%\"></td><td style=\"width:0.1%\"></td></tr><tr><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:2px 1pt;text-align:left;vertical-align:middle\"><div style=\"text-align:right\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%\">2023 Form 10-K</span><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">   |  </span><img alt=\"abbvieimage3.gif\" src=\"abbv-20231231_g2.gif\" style=\"height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:70px\"/></div></td><td colspan=\"3\" style=\"padding:2px 1pt;text-align:left;vertical-align:bottom\"><div style=\"text-align:right\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%\">68</span></div></td></tr></table></div></div></div><div id=\"i891ae87e1630411bb99f581d920680e3_139\"></div></body>"
        ],
        "subtasks": [
            {
                "id": "jun-easy-1-1",
                "query": "What were the total charges associated with the Allergan acquisition integration plan in 2023?",
                "answer": "288,000,000",
                "answer_type": "exact",
                "data_sources": [
                    ""
                ],
                "data_modalities": [
                    ""
                ]
            },
            {
                "id": "jun-easy-1-2",
                "query": "How do the total charges associated with the Allergan acquisition integration pla in 2023 compared to that of 2022?",
                "answer": "2023 charges are lower than 2022 charges by $251 millions.",
                "answer_type": "string_approximate",
                "data_sources": [
                    ""
                ],
                "data_modalities": [
                    ""
                ]
            }
        ]
    },
    {
        "id": "jun-medium-1",
        "query": "Explain the difference between the \"charges associated with the integration plan\" and the \"cash activity in the recorded liability\" section. How does each one impact the company's financial statements differently?",
        "answer": "Charges associated with the integration plan represent the total costs incurred (expenses) related to the integration of Allergan, such as R&D, SG&A, and cost of products sold. These are recorded on the income statement and impact net income. Cash activity in the recorded liability tracks how much cash has been actually paid out for those expenses or obligations. It provides information about the cash flow and is reflected on the cash flow statement. The key difference is that charges are an accrual accounting entry, while cash activity tracks actual payments. For instance, charges can be recorded in a period, but the payment may happen later (in the following year, for example), which affects the cash flow but not the income statement in the same period.",
        "answer_type": "string_approximate",
        "data_sources": [
            ""
        ],
        "subtasks": []
    },
    {
        "id": "jun-medium-2",
        "query": "Calculate the percentage change in total restructuring charges from 2022 to 2023. What does this change indicate about the company's restructuring efforts?",
        "answer": "The total restructuring charges decreased by approximately 45.23% from 2022 to 2023. This significant drop suggests that the company might be nearing the completion of major restructuring activities or has scaled back such efforts. As an investor, this reduction could signal cost stabilization, but it would be important to monitor whether the expected benefits of these restructuring efforts have been realized.",
        "answer_type": "string_approximate",
        "data_sources": [
            ""
        ],
        "subtasks": [
            {
                "id": "jun-medium-2-1",
                "query": "Calculate the total restructuring charges in 2022.",
                "answer": "241,000,000",
                "answer_type": "needs_improvement"
            },
            {
                "id": "jun-medium-2-2",
                "query": "Calculate the total restructuring charges in 2023.",
                "answer": "132,000,000",
                "answer_type": "needs_improvement"
            },
            {
                "id": "jun-medium-2-3",
                "query": "Calculate the percentage change in total restructuring charges from 241 millions to 132 millions.",
                "answer": -45.23,
                "answer_type": "numeric_approximate"
            },
            {
                "id": "jun-medium-2-4",
                "query": "What does a percentage change of -45.23% in total restructuring charges from a year to another indicate about the company's restructuring efforts?",
                "answer": "The significant drop in restructuring charges indicates that the company might be nearing the completion of major restructuring activities or has scaled back such efforts.",
                "answer_type": "string_approximate"
            }
        ]
    },
    {
        "id": "jun-medium-3",
        "query": "Calculate the ratio of total cash payments to restructuring charges in 2023. What does this ratio indicate about the company's ability to manage restructuring cash outflows?",
        "answer": " The ratio of cash payments to restructuring charges in 2023 is approximately 81.3%. A ratio of less than 100% indicates that not all restructuring charges are being paid in the same year; part of the charges is carried forward as accrued liabilities. This suggests the company is managing restructuring cash outflows over multiple periods, potentially easing short-term liquidity pressures. However, it also means future cash flow commitments will continue to be impacted by these charges.",
        "answer_type": "string_approximate",
        "data_sources": [
            ""
        ],
        "subtasks": [
            {
                "id": "jun-medium-3-1",
                "query": "Find the total restructuring charges in 2023.",
                "answer": "107,000,000",
                "answer_type": "needs_improvement"
            },
            {
                "id": "jun-medium-3-2",
                "query": "Find the cash payments and other adjustments in 2023.",
                "answer": "87,000,000",
                "answer_type": "needs_improvement"
            },
            {
                "id": "jun-medium-3-3",
                "query": "Calculate the ratio of cash payments ($87 millions) to restructuring charges ($107 millions).",
                "answer": "81.3",
                "answer_type": "needs_improvement"
            },
            {
                "id": "jun-medium-3-4",
                "query": "What does a cash payments to restructuring charges ratio of 81.3% in a year indicate about the company's ability to manage restructuring cash outflows?",
                "answer": "A ratio of less than 100% indicates that not all restructuring charges are being paid in the same year; part of the charges is carried forward as accrued liabilities.",
                "answer_type": "string_approximate"
            }
        ]
    },
    {
        "id": "jun-hard-1",
        "query": "What is the cumulative cash outflow related to restructuring payments and other adjustments from 2021 to 2023, and how does this impact the company's liquidity if the starting cash balance in 2021 was $1,200 million?",
        "answer": "Given that the starting cash balance in 2021 was $1,200 million, we can assess the liquidity impact by subtracting the total cash outflow over the period from the initial balance: starting cash balance (2021): $1,200 million. Total cash outflow (2021-2023): $(1,769) million. Ending cash balance $569 millions. This indicates that, without other cash inflows or adjustments, the company would have faced a cash shortfall of $569 million by the end of 2023, potentially impacting its liquidity position. However, this shortfall is theoretical based only on the restructuring-related cash flows, and other factors such as revenue, financing, and operational cash flows could affect the actual liquidity outcome.",
        "answer_type": "string_approximate",
        "data_sources": [
            ""
        ],
        "subtasks": []
    }
]